RNA was isolated from skeletal muscle samples (~10 mg) as demonstrated previously (17). Muscle tissue was homogenized in TriReagent following specific manufacturer instructions for aqueous phase separation and precipitation and washing of the RNA pellet (RT 111; Molecular Research Center, Cincinnati, OH). RNA concentration was quantified and assessed for RNA purity using the 260/280 nm ratio (1.88 ± 0.04). Approximately 1 μg of total RNA was synthesized using a commercially available kit (iScript, Bio-Rad, Hercules, CA). Real-time PCR was carried out with a CFX Connect real-time PCR cycler (Bio-Rad) under similar protocol conditions as reported previously (17) using either TaqMan fluorescence predesigned or SYBR green custom designed primers. Each reaction tube consisted of a SYBR Green or TaqMan master mix along with ultrafiltered water and specific forward and reverse primers for a total reaction volume of either 25 or 20 μl, respectively. For SYBR green, we used the following PCR temperature conditions: 1 cycle for 3 min at 95°C followed by 40 cycles at 95°C for 20 s and at 55°C (or 60°C) for 30 s. TaqMan PCR assays (Thermo Fisher Scientific, Waltham, MA) were performed under the recommended PCR temperature guidelines: 1 cycle for 10 min at 95°C followed by 40 cycles at 95°C for 15 s and at 60°C for 60 s. The following TaqMan primers were used: TLR2 (Hs01872448_s1), RAGE (Hs00179504_m1), TAK1 (Hs00177373_m1), IL6 (Hs00985639_m1), and HMGB1 (Hs1923466_g1). MYD88, MCP1, NFKB1 and β2M primers have been designed and published previously (18, 37). The remaining SYBR green primers were designed for this study using standard optimization guidelines (58): TLR4 (NM_138554) (Fwd: 5′-TTCTTCTAACTTCCTCTCCTGTGA-3′, Rev: 5′-AGCGGCAACCTTAGCATTC-3′), TNF associated factor 6, E3 ubiquitin protein ligase (TRAF6; NM_145803) (Fwd: 5′-TTTGCTCTTATGGATTGTCCCC-3′ Rev: 5′-CATTGATGCAGCACAGTTGTC-3′), serine palmitoyltransferase long chain base subunit 1 (SPT1; NM_006415) (Fwd: 5′-TTCCAGTCTTCGTTGTGT-3′, Rev: 5′-GGCTAAGGATGCTCAGAT-3′), serine palmitoyltransferase long chain base subunit 1 (SPT2; NM_004863) (Fwd: 5′-AAGAATCCAGCCATCGTA-3′, Rev: 5′-ATGACTACAGAAGCAAGAATC-3′), ceramide synthase 1 (CERS1; NM_021267) (Fwd: 5′-CCATCTCCGTGCTCTTCTT-3′, Rev: 5′-CACTCGTCCACCACCATG-3′), ceramide synthase 2 (CERS2; NM_181746) (Fwd: 5′-TGGCAATAAGTGTCAGAC-3′, Rev: 5′-GCAAGGAAGGCATAAGAA-3′), and sphingosine kinase 1 (SPHK1; NM_021972) (Fwd: 5′-TATGAATGCCCCTACTTG-3′, Rev: 5′-TCGCTAACCATCAATTCC-3′). All designed primers were carefully optimized for efficiency (between 90 and 110%) and verified by melt analysis and product size using a DNA agarose gel. Cycle threshold values were normalized to beta 2-microglobulin (β2M) for comparisons of Pre vs. Post exercise training in HipFx. However, due to difficulties identifying a stable housekeeping gene (β2M, GAPDH, and HMBS) or calculating geometric means between HipFx and CON and in the interests of preserving limited cDNA, we used chemokine receptor type 2 (CCR2; Hs00704702_s1) as a normalizing gene because it remained stable across the exercise intervention and between groups. Fold change values were calculated using the 2−ΔΔCt method. In the case of comparing Pre vs. Post HipFx gene expression, Pre values were used as the comparator; thus Pre HipFx values were approximately set to 1. In the case of comparing HipFx samples against CON, the CON values were used as the comparator; thus CON values were approximately set to 1.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.